Potential role of natural killer cell receptor-expressing cells in immunotherapy for leukemia (Q36045773)

11 August 2017

1 reference

title

Potential role of natural killer cell receptor-expressing cells in immunotherapy for leukemia (English)

1 reference

11 August 2017

1 reference

Junji Tanaka

1

1 reference

11 August 2017

Masahiro Asaka

series ordinal

2

1 reference

11 August 2017

Masahiro Imamura

series ordinal

3

1 reference

11 August 2017

publication date

1 January 2005

1 reference

International Journal of Hematology

11 August 2017

published in

1 reference

11 August 2017

volume

81

1 reference

11 August 2017

issue

1

1 reference

11 August 2017

page(s)

6-12

1 reference

Determinants of antileukemia effects of allogeneic NK cells

11 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1532%2FIJH97.04152

IL-2-Activated CD8+CD44high Cells Express Both Adaptive and Innate Immune System Receptors and Demonstrate Specificity for Syngeneic Tumor Cells

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1532%2FIJH97.04152

Selective Expansion and Partial Activation of Human NK Cells and NK Receptor-Positive T Cells by IL-2 and IL-15

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1532%2FIJH97.04152

Expression of CD94/NKG2-A on human T lymphocytes is induced by IL-12: implications for adoptive immunotherapy

21 January 2018

1 reference

12 December 2020

NKG2D engagement of colorectal cancer-specific T cells strengthens TCR-mediated antigen stimulation and elicits TCR independent anti-tumor activity

1 reference

12 December 2020

Immunobiology of natural killer lymphocytes in transplantation

1 reference

12 December 2020

Immunoregulatory Cells for Transplantation Tolerance and Graft-versus-Leukemia Effect

1 reference

12 December 2020

Valpha24+ natural killer T-cell responses against T-acute lymphoblastic leukaemia cells: implications for immunotherapy

1 reference

12 December 2020

Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis

1 reference

12 December 2020

Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. Japan Marrow Donor Program

1 reference

12 December 2020

NK cells in allogeneic bone marrow transplantation

1 reference

12 December 2020

Loss of HLA molecules in B lymphomas is associated with an aggressive clinical course

1 reference

12 December 2020

Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance.

1 reference

12 December 2020

Evaluation of natural killer cell expansion and activation in vivo with daily subcutaneous low-dose interleukin-2 plus periodic intermediate-dose pulsing.

1 reference

12 December 2020

IL-21 induces both rapid maturation of human CD34+ cell precursors towards NK cells and acquisition of surface killer Ig-like receptors

1 reference

12 December 2020

Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect

1 reference

12 December 2020

A new era for cancer immunotherapy based on the genes that encode cancer antigens

1 reference

12 December 2020

Postremission therapy with low-dose interleukin 2 with or without intermediate pulse dose interleukin 2 therapy is well tolerated in elderly patients with acute myeloid leukemia: Cancer and Leukemia Group B study 9420.

1 reference

12 December 2020

Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors

1 reference

12 December 2020

KIR expression on self-reactive CD8+ T cells is controlled by T-cell receptor engagement

1 reference

12 December 2020

Increased proportion of HLA-class-I-specific natural killer cell receptors (CD94) on peripheral blood mononuclear cells after allogeneic bone marrow transplantation

1 reference

12 December 2020

Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells

1 reference

12 December 2020

HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C

1 reference

12 December 2020

Cytolytic activity and regulatory functions of inhibitory NK cell receptor-expressing T cells expanded from granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells

1 reference

12 December 2020

The impact of donor KIR and patient HLA-C genotypes on outcome following HLA-identical sibling hematopoietic stem cell transplantation for myeloid leukemia

1 reference

12 December 2020

Granzyme A loading induces rapid cytolysis and a novel form of DNA damage independently of caspase activation

1 reference

12 December 2020

Loss or downregulation of HLA class I expression at the allelic level in acute leukemia is infrequent but functionally relevant, and can be restored by interferon

1 reference

12 December 2020

HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1- and NK2-specific natural killer cells

1 reference

12 December 2020

MIC genes: from genetics to biology

1 reference

12 December 2020

An activating immunoreceptor complex formed by NKG2D and DAP10

1 reference

12 December 2020

Activating and inhibitory NK cell receptors

1 reference

12 December 2020

Augmentation of antitumor effects by NK cell inhibitory receptor blockade in vitro and in vivo

1 reference

12 December 2020

Sequential analysis of HLA-C-specific killer cell inhibitory receptor (CD158b) expressing peripheral blood mononuclear cells during chronic graft-versus-host disease

1 reference

12 December 2020

Expansion of Philadelphia chromosome-negative CD3(+)CD56(+) cytotoxic cells from chronic myeloid leukemia patients: in vitro and in vivo efficacy in severe combined immunodeficiency disease mice

1 reference

12 December 2020

Enhanced cytotoxicity of allogeneic NK cells with killer immunoglobulin-like receptor ligand incompatibility against melanoma and renal cell carcinoma cells

1 reference

12 December 2020

Development and functions of natural killer cells

1 reference

12 December 2020

Expression of HLA-C-specific natural killer cell receptors (CD158a and CD158b) on peripheral blood mononuclear cells after allogeneic bone marrow transplantation

1 reference

12 December 2020

A phase III randomized study of interleukin-2 lymphokine-activated killer cell immunotherapy combined with chemotherapy or radiotherapy after curative or noncurative resection of primary lung carcinoma

1 reference

12 December 2020

The UL16-binding proteins, a novel family of MHC class I-related ligands for NKG2D, activate natural killer cell functions

1 reference

12 December 2020

HLA class I antigens in human tumors.

1 reference

12 December 2020

Roles of the NKG2D immunoreceptor and its ligands

1 reference

12 December 2020

Role of NKG2D in tumor cell lysis mediated by human NK cells: cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin

1 reference

12 December 2020

Studies of ex vivo activated and expanded CD8+ NK-T cells in humans and mice

1 reference

12 December 2020

Identification of HLA-E-specific alloreactive T lymphocytes: a cell subset that undergoes preferential expansion in mixed lymphocyte culture and displays a broad cytolytic activity against allogeneic cells

1 reference

12 December 2020

Down-regulation of HLA-A and HLA-Bw6, but not HLA-Bw4, allospecificities in leukemic cells: an escape mechanism from CTL and NK attack?

1 reference

12 December 2020

Biology and clinical impact of human natural killer cells

1 reference

12 December 2020

Total lymphoid irradiation nonmyeloablative preconditioning enriches for IL-4-producing CD4+-TNK cells and skews differentiation of immunocompetent donor CD4+ cells

1 reference

12 December 2020

CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides

1 reference

12 December 2020

Effective immunotherapy against cancer: a question of overcoming immune suppression and immune escape?

1 reference

12 December 2020

Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants. Killer immunoglobulin-like receptor

1 reference

12 December 2020

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants

1 reference

12 December 2020

Natural killer cell acceptance of H-2 mismatch bone marrow grafts in transgenic mice expressing HLA-Cw3 specific killer cell inhibitory receptor

1 reference

12 December 2020

Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation.

1 reference

12 December 2020

Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity

1 reference

12 December 2020

Association of HLA-C disparity with graft failure after marrow transplantation from unrelated donors

1 reference

12 December 2020

Human CD8+ T lymphocyte subsets that express HLA class I-specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations

1 reference

12 December 2020

Adoptive transfer of cloned melanoma-reactive T lymphocytes for the treatment of patients with metastatic melanoma

1 reference

12 December 2020

Structural specializations of immunoglobulin superfamily members for adhesion to integrins and viruses

1 reference

12 December 2020

Induction of CD94/NKG2A expression on T cells in mixed lymphocyte culture by CD14+ cells from granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells

1 reference

12 December 2020

The HLA-E gene encodes two differentially regulated transcripts and a cell surface protein

1 reference

12 December 2020

In search of the 'missing self': MHC molecules and NK cell recognition

1 reference

12 December 2020

Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia

1 reference

12 December 2020

Superantigen-dependent, cell-mediated cytotoxicity inhibited by MHC class I receptors on T lymphocytes

1 reference

12 December 2020

Tolerance and cancer: mechanisms of tumor evasion and strategies for breaking tolerance

1 reference

12 December 2020

ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor

1 reference

12 December 2020

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes

1 reference

12 December 2020

Natural killer (NK)-cell function and antileukemic activity of a large population of CD3+/CD8+ T cells expressing NK receptors for major histocompatibility complex class I after "three-loci" HLA-incompatible bone marrow transplantation

1 reference

12 December 2020

HLA-E-restricted recognition of cytomegalovirus-derived peptides by human CD8+ cytolytic T lymphocytes

1 reference

12 December 2020

HLA class I-specific inhibitory receptors in human T lymphocytes: interleukin 15-induced expression of CD94/NKG2A in superantigen- or alloantigen-activated CD8+ T cells.

1 reference

12 December 2020

The human leukocyte antigen (HLA)-C-specific "activatory" or "inhibitory" natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions

1 reference

12 December 2020

Modulation of T-cell functions in KIR2DL3 (CD158b) transgenic mice

1 reference

12 December 2020

Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation

1 reference

12 December 2020

A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone

1 reference

12 December 2020

Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease.

1 reference

12 December 2020

Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA

1 reference

12 December 2020

Major histocompatibility complex class I-specific receptors on human natural killer and T lymphocytes

1 reference

12 December 2020

Recovery of Valpha24+ NKT cells after hematopoietic stem cell transplantation

1 reference

12 December 2020

The natural killer T-cell ligand α-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice

1 reference

12 December 2020

CD4pos, NK1.1pos T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3.

1 reference

12 December 2020

Phenotypic and functional analysis of the HLA-class I-specific inhibitory receptors of natural killer cells isolated from peripheral blood of patients undergoing bone marrow transplantation from matched unrelated donors

1 reference

12 December 2020

Melanocyte destruction after antigen-specific immunotherapy of melanoma: direct evidence of t cell-mediated vitiligo.

1 reference

12 December 2020

Role of NKG2D signaling in the cytotoxicity of activated and expanded CD8+ T cells

1 reference

12 December 2020

Analysis of T-cell repertoire and mixed chimaerism in a patient with aplastic anaemia after allogeneic bone marrow transplantation

1 reference

12 December 2020

Loss of surface HLA class I molecules in leukemic myeloblasts is correlated with an increased leukocyte concentration at onset

1 reference

12 December 2020

Non-MHC-restricted cytotoxic cells: their roles in the control and treatment of leukaemias

1 reference

12 December 2020

Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes

1 reference

12 December 2020

Regulation of KIR expression in human T cells: a safety mechanism that may impair protective T-cell responses

1 reference

12 December 2020

Evidence that continued remission in patients treated for acute leukaemia is dependent upon autologous natural killer cells

1 reference

12 December 2020

Expansion of cytolytic CD8(+) natural killer T cells with limited capacity for graft-versus-host disease induction due to interferon gamma production

1 reference

12 December 2020

Killer cell inhibitory receptors for MHC class I molecules regulate lysis of melanoma cells mediated by NK cells, gamma delta T cells, and antigen-specific CTL.

1 reference

12 December 2020

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

1 reference

12 December 2020

Reconstitution of NK cell receptor repertoire following HLA-matched hematopoietic cell transplantation

1 reference

12 December 2020

Phase III randomized trial of interleukin-2 with or without lymphokine-activated killer cells in the treatment of patients with advanced renal cell carcinoma

1 reference

12 December 2020

Identifiers

DOI

10.1532/IJH97.04152

1 reference

Dimensions Publication ID

11 August 2017

1002063750

0 references

1 reference